Back to Search
Start Over
1412TiP Mobocertinib (TAK-788) as first-line treatment vs platinum-based chemotherapy (CT) for NSCLC with EGFR exon 20 insertions (exon20ins).
- Source :
-
Annals of Oncology . 2020 Supplement 4, Vol. 31, pS892-S893. 2p. - Publication Year :
- 2020
Details
- Language :
- English
- ISSN :
- 09237534
- Volume :
- 31
- Database :
- Academic Search Index
- Journal :
- Annals of Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 152696254
- Full Text :
- https://doi.org/10.1016/j.annonc.2020.08.1726